The objective of this study was to investigate the possible regulation of the vitamin K-dependent matrix Gla (y-carboxyglutamic acid) protein (MGP) by retinoic acid, a regulation suggested by the recent observation that the human MGP promoter has a perfect direct repeat which is nearly identical to the retinoic acid-responsive element in the retinoic acid receptor-@ gene. We report that retinoic acid strongly increases MGP mRNA levels in all human cells tested, including osteoblasts, articular cartilage chondrocytes, and fibroblasts. In osteoblastic cells, MGP mRNA levels are increased by 25-fold at 1 pM retinoic acid and achieve half-maximal levels at 0.1 pM hormone. MGP is a small secreted protein of unknown function that is synthesized in a wide variety of vertebrate tissues. The present results suggest that part of the known actions of retinoic acid on skin, bone, cartilage, and other tissues in the human may be mediated by the stimulation of MGP synthesis and the consequent effect of increased MGP secretion on nearby target cells. (Endocrinology 130: 102-108,1992) 
M ATRIX
Gla (y-carboxyglutamic acid) protein (MGP) is a 79-residue protein of unknown function that contains five residues of the vitamin K-dependent calcium-binding amino acid, y-carboxyglutamic acid (Gla) (l-3). MGP was first isolated from the matrix of bone, but is now known to be synthesized in all tissues tested, with the highest levels of synthesis in heart, kidney, lung, and cartilage (4, 5) . We have recently determined the sequence of the human MGP gene and have identified a number of putative regulatory sequences in its promoter (6) . One of the most interesting of these is the perfect direct repeat GGTGAACaaaa GGTGAAC, a sequence that shares a high degree of identity with the retinoic acid-responsive element in the human retinoic acid receptor+ gene promoter, the sequence AGTGAACtttcGGTGAAC (7) . The major objective of the present investigations was to evaluate the possible regulation of MGP expression by retinoic acid in a variety of human cell types. Because MGP is known to be induced by the active metabolite of vitamin D, 1,25-dihydroxyvitamin D3 [1, 2D3] in rat osteosarcoma cells (8, 9) , we have also investigated the effect of this hormone on MGP expression in human cells. In these studies we have used the related vitamin K-dependent protein, bone Gla protein (BGP; osteocalcin), as an internal control, since BGP synthesis is known to be strongly induced by 1, 2D3 in bone cells (lo-12) , and a chloramphenicol acetyltransferase construct of the Received April 26, 1991. * This work was supported in part by USPHS Grant AR-25921. t To whom requests for reprints should be addressed.
human BGP promoter has been shown to be strongly induced by retinoic acid in rat osteosarcoma cells (13) . Retinoic acid is a natural metabolite of vitamin A that exerts profound effects on embryonic differentiation and development in a wide variety of systems (14, 15) . Retinoic acid administration after birth also potently affects skin, bone, and other tissues (16) (17) (18) , and many of the effects of vitamin A deficiency are currently thought to reflect the accompanying deficiency in retinoic acid activity (18). In the absence of retinoic acid supplementation, rats fed a vitamin A-deficient diet cease growth within 2 days, lose weight, and die within 28 days (19). In man, the systemic effects of vitamin A deficiency have been best characterized in the children of underdeveloped countries, where deficiency has been shown to cause reduced growth, blindness, and at least a lo-fold increased mortality from all causes (20). In industrialized countries, several epidemiological studies have also revealed an inverse correlation between vitamin A intake and the incidence of several cancers (21, 22) .
In spite of the profound effects of vitamin A deficiency on mortality and morbidity, most of which can be reversed in animal models by the administration of retinoic acid, relatively little is known about the biochemical actions of retinoic acid in children and adults. Retinoic acid is known to regulate the transcription of specific target genes by a ligand-dependent mechanism analogous to the action of steroid hormones and 1,25-(OH) 2DR (23, 24) , and a number of retinoic acid receptors have been identified (25) (26) (27) (28) 
Materials and Methods
Materials lz51 (4 X 10IR cpm/mol) and [a-"'P]dCTP (>3,000 Ci/mmol) were purchased from Amersham (Arlington Heights, IL). Cell culture medium, calf serum, PBS, antibiotics, fungisone, and trypsin were purchased from Irvine Scientific (Santa Ana, CA), and vitamin C was purchased from Gibco (Grand Island, NY). The human osteosarcoma cell line MG-63 was purchased from American Type Culture Collection (CRL 1427, Rockville, MD). Normal human osteoblasts were obtained by the procedure of Gehron-Robey and Termine (38) from the calvaria of a 20-week-old stillborn fetus and from the proximal femur trabecular bone removed during joint replacement of 68-and 74-yr-old adults. Human articular cartilage chondrocytes from fetal, newborn, and osteoarthritic adult knee joints were a gift from Martin Lotz, and human foreskin fibroblasts were obtained from Charles Johnson. 1,25-(OH)2D3 was a generous gift from M. R. Uskokovik at Hoffman-LaRoche (Nutley, NJ); retinoic acid (all-tram), actinomycin-D, and cycloheximide were purchased from Sigma (St. Louis, MO).
Cell culture MG-63 cells were cultured in RPMI-1640, fetal osteoblasts in Coon's F-12, and adult osteoblasts in a 5050 mixture of Minimum Essential Medium-Earle's salts and Ham's F-12; in each case, medium was supplemented with 10% newborn calf serum. Human chondrocytes from fetal, newborn, and adult articular cartilage were cultured in Dulbecco's Modified Eagle's-high glucose medium supplemented with 10% fetal calf serum, and foreskin fibroblasts were cultured in Minimum Essential Medium-Earle's salts medium supplemented with 10% newborn calf serum. For all cell types, medium was supplemented with 50 pg/ml vitamin C. All cells were transferred to serum-free medium at confluence and were maintained in this medium for 24 h before the beginning of each experiment. The medium in each loo-mm plate was then replaced with 10 ml fresh serum-free medium supplemented with ethanol vehicle, 2.4 nM 1,25-(OH)zD3, 1 pM retinoic acid, or a combination of both hormones. Every subsequent 24 h, the conditioned medium was harvested, centrifuged to remove any cellular debris, and frozen for later analysis by RIA. At the same time, fresh serum-free medium containing the appropriate treatments was added to each plate of cells. Conditioned medium aliquots of 0.2 ml or less were assayed for MGP by RIA, as previously described (39).
RNA isolation/Northern analysis
RNA was isolated by established methods (40, 41). Total RNA was fractionated on 1.4% agarose formaldehyde gels in a 3-[N-morpholinolpropane sulfonic acid buffer and transferred to a nylon membrane (0.45 pm; Nytran, Schleicher and Schuell, Keene, NH), as previously described (42, 43) . Relative mRNA levels were determined using the human BGP,' human MGP (6) , and rat @-actin (44) cDNA clones. The cDNAs were separated from the cloning vectors by gel purification, followed by electroelution (Elutrap, Schleicher and Schuell) and labeled with [cu-"*P]dCTP using a Random Primed DNA Labeling Kit (Boehringer Mannheim, Indianapolis, IN) to a specific activity of at least 1 x lO* cpm/rg. Hybridization to RNA immobilized on Nytran was typically performed for 17 h at 42 C with l-5 X 10fi cpm DNA probe/ml 50% formamide solution containing 5 x SSPE [l x SSPE is 180 mM NaCl, 10 mM NaP04 (pH 7.4), and 1 mM EDTA], 5 x Denhardt's, and 100 pg/ml salmon sperm DNA after prehybridization at 42 C in the same solution without the cDNA probe. Filters were washed in 0.1-0.5 x SSPE containing 0.2% sodium dodecyl sulfate for 10 min at room temperature, followed by 1 h at 55 C. Autoradiography was performed at -70 C with Kodak XAR-5 film (Eastman Kodak, Rochester, NY) and DuPont Cronex Lightning Plus screens (DuPont, Wilmington, DE). RNA size markers (Bethesda Research Laboratories, Gaithersburg, MD) were run on adjacent gel lanes and stained with ethidium bromide. Probes were removed from the membranes by washing at 65 C for 30-60 min with 50-60% formamide in 6 X SSPE. After autoradiography, the relative intensities of the MGP, BGP, and P-actin mRNA bands in the autoradiographs were determined using an LKB Ultrascan XL Laser Densitometer (Rockville, MD). Small variations in the RNA loads were corrected by dividing the relative intensities obtained for MGP and BGP by those obtained for @-actin in the same lane.
Results

Effect of retinoic acid and 1,25-(OH)zDs on MGP and BGP mRNA levels in osteoblastic cells
To evaluate the effects of retinoic acid and 1,25-(OH)zD:3 on the expression of MGP and BGP, confluent cultures of osteoblastic cells were treated for various times with the respective hormones, and the levels of MGP and BGP mRNA were determined by Northern blot. As can be seen in Fig. 1 1 . Northern blot analysis of MGP and BGP mRNA levels in human adult osteoblasts. Cells were preincubated for 24 h in serumfree medium and then treated for 24,48, and 72 h with ethanol vehicle (control), 2.4 IIM 1,25-(OH)*Ds (1,26D& 1 pM retinoic acid (RA), or a combination of both hormones (RA + 1,25D3). Total RNA (30 rg) from each condition was run on a 1.4% agarose-formaldehyde gel and then transferred to Nytran, aa described in Materials and Methods. The membrane was first hybridized with a 3*P-labeled human MGP cDNA then washed and reprobed with a 32P-labeled human BGP cDNA. The amount of RNA loaded in each lane was monitored by hybridization with a rat @-actin cDNA. This experiment was repeated at 24,36, and 72 h using cells from a different human donor, and in each case the hormone responses were essentially identical to those shown here. mRNA, although the response was faster and stronger with 1,25-(OH)zDa treatment.
When these cells were treated with both hormones together, the BGP mRNA response to 1,25-(OH)zD3 was stimulated by retinoic acid at 24, 48, and 72 h, while the MGP mRNA response to retinoic acid was not significantly affected by 1,25-(OW&.
Retinoic acid treatment caused a similar increase in MGP mRNA levels in the MG-63 human osteosarcoma cell line (Fig. 2) . The increase in MGP mRNA levels in retinoic acid-treated cells relative to that in untreated control cells varied from B-to 35fold in different experiments. This variation in apparent response was primarily caused by as yet unexplained differences in basal MGP mRNA expression among these experiments. In contrast to adult osteoblasts, MGP mRNA expression was also strongly induced by 1,25-(OH)2D3, although the response was somewhat slower than that of retinoic acid. BGP synthesis was again strongly induced by 1,25-(OH)zD3 in the MG-63 cells (Fig. 2) , but in contrast with normal osteoblasts, BGP mRNA was not induced by retinoic acid. oblasts, the effect of retinoic acid on MGP mRNA levels was also measured by Northern blot in fibroblasts, articular cartilage chondrocytes, and fetal osteoblasts. As shown in Fig. 3 , retinoic acid strongly increased MGP mRNA levels in each cell type after 24 and 48 h of treatment. An equivalently strong increase in MGP mRNA levels was also seen in chondrocytes from newborn and osteoarthritic adult articular cartilage after 24 and 48 h of retinoic acid treatment (data not shown). Treatment with 1,25-(OH)2D3 alone did not increase MGP mRNA levels in any of these cells, although 1,25-(OH)2D3 treatment did attenuate the retinoic acid response in fetal osteoblasts and chondrocytes (Fig. 3 ) and in fibroblasts (data not shown). In this experiment the level of MGP antigen in the conditioned medium of fetal osteoblasts was sufficient for measurement by RIA. After 48 h of treatment with retinoic acid, MGP levels in the medium of fetal osteoblasts were 6.4-fold higher than those in the medium of untreated cells, while MGP levels in the medium of cells treated with 1,25-(OH)zDs plus retinoic acid were only 3.6-fold higher than those in the medium of untreated cells (data not shown). For comparison, densitometer scanning of the autoradiograph for fetal osteoblasts revealed that MGP mRNA levels were 8.6-fold higher in cells treated for 48 h with retinoic acid ( The autoradiographs shown in Figs The time course and dose dependence of the MGP mRNA response to retinoic acid were evaluated in MG-63 osteosarcoma cells, since these cells grow rapidly and display a retinoic acid response apparently identical to that in the normal cells. As seen in Fig. 4 , MGP mRNA levels were elevated 3-fold by 6 h of treatment with retinoic acid and continued to increase over the 48 h of hormone treatment. As shown in Fig. 5 , the MGP mRNA response was maximal at 1 PM hormone, and half of the maximal response was attained at 0.1 pM. Retinoic acid caused a substantial reduction in cell number at the highest dose tested, which probably accounts for the reduced MGP mRNA level in these cells.
Effect of inhibitors of RNA and protein synthesis on the MGP mRNA response to retinoic acid As can be seen in Fig. 6 , cotreatment of MG-63 cells with retinoic acid and either the protein synthesis inhibitor cycloheximide or the RNA synthesis inhibitor acti- Results are expressed as the MGP mRNA hybridization density for each concentration of retinoic acid divided by the density in untreated control cells. This experiment was repeated once, with essentially identical results.
probably requires both RNA and protein synthesis. Since actinomycin-D did not significantly reduce MGP mRNA levels in control cells, it is also probable that the halflife of MGP mRNA turnover is substantially longer than the 14 h of actinomycin-D treatment.
Discussion
The present results suggest that MGP could mediate some of the known effects of retinoic acid on cell growth and differentiation in a wide variety of human tissues. Retinoic acid strongly stimulated MGP mRNA levels in all human cells tested, which include osteoblasts, chondrocytes, and fibroblasts from fetal, newborn, and adult tissues, and it seems probable that MGP is also regulated by retinoic acid in the many additional cells and tissues that express the protein (4, 5) . The function of MGP itself is presently unknown. It is small (79 residues), has five residues of the vitamin K-dependent Ca'+-binding amino acid y-carboxyglutamic acid, and has two conserved dibasic sequences, one of which is a site of proteolytic processing (2, 3) . The protein was first discovered as a component of the bone morphogenetic material (l), although it is not presently considered to be critical for bone induction, and has been identified by differential screening as a gene that is strongly expressed by breast cancer cells (45). We speculate that MGP is a locally acting regulator of cell growth and/or differentiation in a wide variety of tissues, and that a part of the action of retinoic acid on different tissues is achieved by the stimulation of MGP synthesis and the subsequent effect of increased MGP secretion on nearby target cells.
It seems probable that retinoic acid increases MGP The results are given as the MGP mRNA density for each treatment divided by the density in the untreated control. This experiment was repeated with MG-63 cells after 24 h of treatment and with human fibroblasts after 14 h of treatment; in each instance, inhibitors of RNA and protein synthesis blocked the MGP response to retinoic acid without significantly affecting basal MGP mRNA levels. mRNA levels by binding to a retinoic acid receptor, which, in turn, binds to the putative retinoic acid-responsive element in the human MGP gene promoter and activates MGP gene transcription.
Most of the genes known to be induced by retinoic acid are thought to be regulated at the transcriptional level by this mechanism (7, 33) , and the putative retinoic acid-responsive element in the MGP gene promoter is essentially identical to the well characterized retinoic acid-responsive element present in the human retinoic acid receptor+ gene promoter (7) . In addition, the time course and dose dependence of the MGP mRNA response to retinoic acid are essentially identical to those in genes known to be activated transcriptionally by this hormone (31, 33). We have shown that 0.05 PM of the transcriptional inhibitor actinomytin-D does, in fact, block the induction of MGP mRNA by retinoic acid. The induction of MGP mRNA is also prevented by 5 pM of the protein synthesis inhibitor cycloheximide. Cycloheximide blocks or significantly diminishes the action of retinoic acid on several genes that have been shown by other evidence to be regulated at the transcriptional level by this hormone (30, 46) , and therefore, it is possible that MGP and other genes induced by retinoic acid may require a rapidly turned over transcriptional factor for the retinoic acid receptor-dependent induction of transcription.
We are presently investigating the possible functions of the putative retinoic acid-responsive element in the MGP gene promoter in the MGP mRNA response to this hormone.
Our results show that 1,25-(OH)zD3 by itself has no significant effect on MGP gene expression in any normal human cell analyzed, but strongly increases MGP mRNA in the human osteosarcoma cell MG-63. A similar strong induction of MGP mRNA by 1,25-(OH)2D3 has been reported in UMR 106 and ROS 17/2 rat osteosarcoma cells (8, 9) . The absence of a MGP mRNA response to 1,25-(OH)2D3 in adult osteoblasts cannot be due to an absence of vitamin D receptors, since there is a strong BGP mRNA response to 1,25-(OH)2D3 in these cells. One possible explanation for the absence of MGP mRNA induction in normal adult osteoblasts could be that there is a fundamental difference in the 1,25-(OH)zD3 response pattern between tumorigenic and nontumorigenic cells, a difference that has been postulated in earlier studies on the hormonal response of bone cells (47). Although 1,25-(OH)zDs did not induce MGP mRNA in normal human cells, it did attenuate the MGP mRNA response to retinoic acid in chondrocytes, fibroblasts, and fetal osteoblasts. The antagonism between vitamins A and D has been noted in animal studies (48) and could reflect heterodimer formation between these related receptors (23, 24), as has been shown for thyroid and retinoic acid receptors (49).
In the present report, 1,25-(OH)2D3 was found to increase the levels of BGP mRNA in adult osteoblasts and in the MG-63 human osteosarcoma cell line. Although the induction of BGP mRNA by 1,25-(OH)zD3 in normal human osteoblasts has not been reported previously, this result is consistent with the increase in BGP secretion in response to 1,25-(OH)*D3 in these cells (11) and with previous studies on the BGP mRNA response to 1,25-(OH)zD3 in MG-63 and other osteoblastic cells (9, 50, 51) . In normal osteoblasts, retinoic acid alone also significantly increased BGP mRNA levels, although this response was somewhat delayed and less strong than the BGP mRNA induction by 1,25-(OH)2D3 in these cells. This result is in good agreement with previous studies on the hormonal induction of BGP at the protein level in these cells (52), and with recent investigations which have shown that retinoic acid as well as 1,25-(OH)zD3 can induce transcription of a chimeric construct in which a fragment of the human BGP gene promoter is fused to the bacterial chloramphenicol acetyltransferase gene and transfected into the ROS 17/2 rat osteosarcoma cell line (13) . The failure of retinoic acid to increase BGP mRNA in MG-63 cells could again reflect an altered control of gene transcription by steroid hormones in tumorigenic cells.
